Mallinckrodt (2013)   Report issue

Founded: St Louis MO United States (2013)
Status: Left NME R&D (2023)

Organization Overview

First Clinical Trial
None
First Marketed Drug
2017
buprenorphine
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree